{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:02:54Z","timestamp":1790290974443,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nutr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) represents a growing metabolic and hepatic health challenge worldwide, particularly in low- and middle-income regions such as Iraq. This study aimed to evaluate the safety and effectiveness of a combined nutrition education program and omega-3 fatty acid supplementation in improving anthropometric, biochemical, and hepatic outcomes among patients with NAFLD in Erbil City.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This randomized controlled trial study was conducted from November 3rd, 2024 to March 3rd, 2025, at the outpatient clinic of Rizgary Teaching Hospital in Erbil City, Kurdistan Region, Iraq, using systematic sampling method. Data were collected using a structured questionnaire consisting of sociodemographic and clinical characteristics, anthropometric and biochemical measurements, the International Physical Activity Questionnaire (IPAQ), and dietary behavior scales. Statistical analyses were performed using IBM SPSS version 26 (IBM Corp., Armonk, NY).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 162 patients with non-alcoholic fatty liver disease (NAFLD) were included in the study. Both omega-3 supplementation and nutrition education interventions significantly improved anthropometric and biochemical parameters compared to baseline values. The nutrition education group achieved greater reductions in body weight (\u2212\u20092.83\u00a0kg,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), BMI (\u2212\u20091.00\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and liver enzymes (ALT and AST,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), along with improved lipid profiles and dietary behaviors. Total physical activity levels increased significantly in both intervention groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Hierarchical multiple regression identified nutrition education (\u03b2\u2009=\u20090.428,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), omega-3 supplementation (\u03b2\u2009=\u20090.312,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), physical activity change (\u03b2\u2009=\u20090.284,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and compliance (\u03b2\u2009=\u20090.258,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) as key predictors of treatment success, collectively explaining 61% of the variance in outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study demonstrated that a nutrition education and omega-3 supplementation program effectively improved hepatic function, lipid profile, and physical activity among patients with NAFLD in Erbil City. Integrating such low-cost, behaviorally oriented interventions into clinical practice may provide a sustainable approach for NAFLD management in resource-limited settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The clinical trial was prospectively registered at ClinicalTrials.gov (Identifier: NCT06627114; Registration date: October 2, 2024).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40795-026-01309-0","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:25:01Z","timestamp":1776338701000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of nutrition education program and omega-3 supplementation on body weight, liver enzyme, lipid profile among non-alcoholic fatty liver disease patients"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9814-1916","authenticated-orcid":false,"given":"Dilkhosh Shamal","family":"Ramadhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Hasan","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"1","key":"1309_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1210\/endrev\/bnz009","volume":"41","author":"T Marjot","year":"2020","unstructured":"Marjot T, Moolla A, Cobbold JF, Hodson L, Tomlinson JW. Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management. Endocr Rev. 2020;41(1):66\u2013117.","journal-title":"Endocr Rev"},{"issue":"1","key":"1309_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"JV Lazarus","year":"2022","unstructured":"Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19(1):60\u201378.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1309_CR3","doi-asserted-by":"crossref","unstructured":"Krag A, Negro F, Shawcross DL. Closing the gap: why liver health must be central to the United Nations Political Declaration on Non-Communicable Diseases. J Hepatol. 2026;84(1):5\u20139.","DOI":"10.1016\/j.jhep.2025.10.015"},{"issue":"2","key":"1309_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cld.2023.01.014","volume":"27","author":"J Ong","year":"2023","unstructured":"Ong J, Alswat K, Hamid S, El-Kassas M. Nonalcoholic fatty liver disease in Asia, Africa, and Middle East region. Clin Liver Dis. 2023;27(2):287\u201399.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"1309_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrcardio.2017.138","volume":"15","author":"K Turk-Adawi","year":"2018","unstructured":"Turk-Adawi K, Sarrafzadegan N, Fadhil I, Taubert K, Sadeghi M, Wenger NK, et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2018;15(2):106\u201319.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1309_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s13555-019-00332-3","volume":"9","author":"YI Lopez Carrera","year":"2019","unstructured":"Lopez Carrera YI, Al Hammadi A, Huang Y-H, Llamado LJ, Mahgoub E, Tallman AM. Epidemiology, diagnosis, and treatment of atopic dermatitis in the developing countries of Asia, Africa, Latin America, and the Middle East: a review. Dermatol Ther. 2019;9(4):685\u2013705.","journal-title":"Dermatol Ther"},{"key":"1309_CR7","doi-asserted-by":"crossref","unstructured":"Baynes K: Diabetes mellitus, obesity, lipoprotein disorders and other metabolic diseases. In: Medicine for Finals and Beyond. edn.: CRC Press; 2022: 429\u2013470.","DOI":"10.1201\/9781003193616-11"},{"key":"1309_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.14484","volume":"24","author":"CD Byrne","year":"2022","unstructured":"Byrne CD, Targher G. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications. Diabetes Obes Metab. 2022;24:28\u201343.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"1309_CR9","doi-asserted-by":"publisher","first-page":"166763","DOI":"10.1016\/j.bbadis.2023.166763","volume":"1870","author":"L Fabris","year":"2024","unstructured":"Fabris L, Campello E, Cadamuro M, Simioni P. The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): looking for the culprit. Biochim Biophys Acta Mol Basis Dis. 2024;1870(3):166763.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1309_CR10","first-page":"117955142096448","volume":"13","author":"MA Lim","year":"2020","unstructured":"Lim MA, Pranata R. The danger of sedentary lifestyle in diabetic and obese people during the COVID-19 pandemic. Clin Med Insights: Endocrinol Diabetes. 2020;13:1179551420964487.","journal-title":"Clin Med Insights: Endocrinol Diabetes"},{"issue":"Suppl 1","key":"1309_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12902-019-0463-3","volume":"20","author":"I Kyrou","year":"2020","unstructured":"Kyrou I, Tsigos C, Mavrogianni C, Cardon G, Van Stappen V, Latomme J, et al. Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe. BMC Endocr Disord. 2020;20(Suppl 1):134.","journal-title":"BMC Endocr Disord"},{"key":"1309_CR12","doi-asserted-by":"publisher","first-page":"1527328","DOI":"10.3389\/fpubh.2025.1527328","volume":"13","author":"Q Nie","year":"2025","unstructured":"Nie Q, Jiang Y, Li M, Liang Q, Mo X, Qiu T, et al. Global burden and international disparities in NASH-associated liver cancer: mortality trends (1990\u20132021) and future projections to 2045. Front Public Health. 2025;13:1527328.","journal-title":"Front Public Health"},{"issue":"Suppl","key":"1309_CR13","doi-asserted-by":"publisher","first-page":"S286","DOI":"10.3350\/cmh.2022.0392","volume":"29","author":"S Battistella","year":"2022","unstructured":"Battistella S, D\u2019Arcangelo F, Grasso M, Zanetto A, Gambato M, Germani G, et al. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management. Clin Mol Hepatol. 2022;29(Suppl):S286.","journal-title":"Clin Mol Hepatol"},{"issue":"9","key":"1309_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599\u2013612.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1309_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/17474124.2023.2172397","volume":"17","author":"Y Gu","year":"2023","unstructured":"Gu Y, Sun L, He Y, Yang L, Deng C, Zhou R, et al. Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials. Expert Rev Gastroenterol Hepatol. 2023;17(3):273\u201382.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"1309_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-nutr-061021-030223","volume":"43","author":"MH Spooner","year":"2023","unstructured":"Spooner MH, Jump DB. Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use. Annu Rev Nutr. 2023;43(1):199\u2013223.","journal-title":"Annu Rev Nutr"},{"issue":"sup1","key":"1309_CR17","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.1080\/10408398.2018.1544542","volume":"59","author":"M Wang","year":"2019","unstructured":"Wang M, Ma L-J, Yang Y, Xiao Z, Wan J-B. N-3 polyunsaturated fatty acids for the management of alcoholic liver disease: a critical review. Crit Rev Food Sci Nutr. 2019;59(sup1):S116\u201329.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1309_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2025.05.013","author":"SJ Kim","year":"2025","unstructured":"Kim SJ, Cho SH, Yun JM. Omega-3 polyunsaturated fatty acids and Nonalcoholic fatty liver disease in adults: a meta-analysis of randomized controlled trials. Clin Nutr. 2025. https:\/\/doi.org\/10.1016\/j.clnu.2025.05.013.","journal-title":"Clin Nutr"},{"issue":"9","key":"1309_CR19","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.3390\/nu12092769","volume":"12","author":"CH Lee","year":"2020","unstructured":"Lee CH, Fu Y, Yang SJ, Chi CC. Effects of omega-3 polyunsaturated fatty acid supplementation on non-alcoholic fatty liver: a systematic review and meta-analysis. Nutrients. 2020;12(9):2769.","journal-title":"Nutrients"},{"issue":"1","key":"1309_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12902-021-00856-w","volume":"21","author":"M Panbehkar-Jouybari","year":"2021","unstructured":"Panbehkar-Jouybari M, Mollahosseini M, Salehi-Abargouei A, Fallahzadeh H, Mirzaei M, Hosseinzadeh M. The Mediterranean diet and dietary approach to stop hypertension (DASH)-style diet are differently associated with lipid profile in a large sample of Iranian adults: a cross-sectional study of Shahedieh cohort. BMC Endocr Disord. 2021;21(1):192.","journal-title":"BMC Endocr Disord"},{"key":"1309_CR21","doi-asserted-by":"publisher","first-page":"105074","DOI":"10.1016\/j.jff.2022.105074","volume":"92","author":"MA Farhangi","year":"2022","unstructured":"Farhangi MA, Dehghan P, Musazadeh V, Kavyani M, Maleki P. Effectiveness of omega-3 and prebiotics on adiponectin, leptin, liver enzymes lipid profile and anthropometric indices in patients with non-alcoholic fatty liver disease: a randomized controlled trial. J Funct Foods. 2022;92:105074.","journal-title":"J Funct Foods"},{"key":"1309_CR22","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11165-016-9602-2","volume":"48","author":"KS Taber","year":"2018","unstructured":"Taber KS. The use of Cronbach\u2019s alpha when developing and reporting research instruments in science education. Res Sci Educ. 2018;48:1273\u201396.","journal-title":"Res Sci Educ"},{"issue":"8","key":"1309_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"1309_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00394-019-01926-5","volume":"59","author":"C Bredin","year":"2020","unstructured":"Bredin C, Naimimohasses S, Norris S, Wright C, Hancock N, Hart K, et al. Development and relative validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients. Eur J Nutr. 2020;59(2):571\u201380.","journal-title":"Eur J Nutr"},{"issue":"1","key":"1309_CR25","doi-asserted-by":"publisher","first-page":"3465980","DOI":"10.1155\/2022\/3465980","volume":"2022","author":"N Mobasheri","year":"2022","unstructured":"Mobasheri N, Ghahremani L, Fallahzadeh Abarghooee E, Hassanzadeh J. Lifestyle intervention for patients with nonalcoholic fatty liver disease: a randomized clinical trial based on the theory of planned behavior. Biomed Res Int. 2022;2022(1):3465980.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1309_CR26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","volume":"56","author":"HM Parker","year":"2012","unstructured":"Parker HM, Johnson NA, Burdon CA, Cohn JS, O\u2019Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56(4):944\u201351.","journal-title":"J Hepatol"},{"issue":"10290","key":"1309_CR27","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"1309_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","volume":"5","author":"S Mitra","year":"2020","unstructured":"Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol. 2020;5:16.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"3","key":"1309_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-180469","volume":"66","author":"KA Walker","year":"2018","unstructured":"Walker KA, Windham BG, Brown CH IV, Knopman DS, Jack CR Jr, Mosley TH Jr, et al. The association of mid-and late-life systemic inflammation with brain amyloid deposition: the ARIC-PET study. J Alzheimers Dis. 2018;66(3):1041\u201352.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1309_CR30","doi-asserted-by":"publisher","first-page":"e042843","DOI":"10.1136\/bmjopen-2020-042843","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, et al. Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open. 2021;11(5):e042843.","journal-title":"BMJ Open"},{"issue":"2","key":"1309_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","volume":"75","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, Gawrieh S, Roberts K, Lisanti CJ, Schwope RB, Cebe KM, et al. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort. J Hepatol. 2021;75(2):284\u201391.","journal-title":"J Hepatol"},{"issue":"1","key":"1309_CR32","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1186\/s12889-022-14569-9","volume":"22","author":"A Saha","year":"2022","unstructured":"Saha A, Rahaman M, Mandal B, Biswas S, Govil D. Rural urban differences in self-rated health among older adults: examining the role of marital status and living arrangements. BMC Public Health. 2022;22(1):2175.","journal-title":"BMC Public Health"},{"issue":"11","key":"1309_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.2018.13022","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA. 2018;320(11):1163\u201371.","journal-title":"JAMA"},{"issue":"2","key":"1309_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pcad.2018.06.001","volume":"61","author":"RF Kushner","year":"2018","unstructured":"Kushner RF. Weight loss strategies for treatment of obesity: lifestyle management and pharmacotherapy. Prog Cardiovasc Dis. 2018;61(2):246\u201352.","journal-title":"Prog Cardiovasc Dis"},{"issue":"23","key":"1309_CR35","doi-asserted-by":"publisher","first-page":"12797","DOI":"10.3390\/ijms222312797","volume":"22","author":"M Mavromati","year":"2021","unstructured":"Mavromati M, Jornayvaz FR. Hypothyroidism-associated dyslipidemia: potential molecular mechanisms leading to NAFLD. Int J Mol Sci. 2021;22(23):12797.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1309_CR36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep4.1241","volume":"2","author":"O Shahab","year":"2018","unstructured":"Shahab O, Biswas R, Paik J, Bush H, Golabi P, Younossi ZM. Among patients with NAFLD, treatment of dyslipidemia does not reduce cardiovascular mortality. Hepatol Commun. 2018;2(10):1227\u201334.","journal-title":"Hepatol Commun"},{"issue":"5","key":"1309_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s40495-018-0147-0","volume":"4","author":"BL Woolbright","year":"2018","unstructured":"Woolbright BL, Jaeschke H. Mechanisms of inflammatory liver injury and drug-induced hepatotoxicity. Curr Pharmacol Rep. 2018;4(5):346\u201357.","journal-title":"Curr Pharmacol Rep"},{"issue":"3","key":"1309_CR38","doi-asserted-by":"publisher","first-page":"G329","DOI":"10.1152\/ajpgi.00044.2018","volume":"315","author":"S Hohenester","year":"2018","unstructured":"Hohenester S, Christiansen S, Nagel J, Wimmer R, Artmann R, Denk G, et al. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. Am J Physiol Gastrointest Liver Physiol. 2018;315(3):G329\u201338.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"06","key":"1309_CR39","first-page":"2380","volume":"13","author":"D Singh","year":"2023","unstructured":"Singh D, Biju B, Kumar L, Arya S, Singh A. Assessing the impact of health education on health behavior change. J Chem Health Risks. 2023;13(06):2380\u20137.","journal-title":"J Chem Health Risks"},{"key":"1309_CR40","doi-asserted-by":"publisher","first-page":"1063316","DOI":"10.3389\/fnut.2023.1063316","volume":"10","author":"BY Amoore","year":"2023","unstructured":"Amoore BY, Gaa PK, Amalba A, Mogre V. Nutrition education intervention improves medical students\u2019 dietary habits and their competency and self-efficacy in providing nutrition care: a pre, post and follow-up quasi-experimental study. Front Nutr. 2023;10:1063316.","journal-title":"Front Nutr"},{"issue":"2","key":"1309_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11606-017-4197-5","volume":"33","author":"KR Amico","year":"2018","unstructured":"Amico KR, Mugavero M, Krousel-Wood MA, Bosworth HB, Merlin JS. Advantages to using social-behavioral models of medication adherence in research and practice. J Gen Intern Med. 2018;33(2):207\u201315.","journal-title":"J Gen Intern Med"}],"container-title":["BMC Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40795-026-01309-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-026-01309-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40795-026-01309-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:12:37Z","timestamp":1781647957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40795-026-01309-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1186\/s40795-026-01309-0","relation":{},"ISSN":["2055-0928"],"issn-type":[{"value":"2055-0928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Ethical Committee of the College of Nursing, Hawler Medical University, under approval code 243, granted on June 2, 2024. This study was also conducted in full accordance with the ethical principles outlined in the Declaration of Helsinki (2013 revision) and complied with national and institutional research ethics standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No identifying personal or clinical details of participants are included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}